Eltrombopag – a novel approach for the treatment of chronic immune thrombocytopenic purpura: review and safety considerations
Lucy Cook, Nichola CooperDepartment of Haematology, Imperial Health Care NHS Trust, Hammersmith Hospital, London, UKAbstract: Eltrombopag is one of a number of novel agents recently developed for use in the treatment of patients with immune thrombocytopenia (ITP). Rather than preventing destruction...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Knjiga |
| Izdano: |
Dove Medical Press,
2010-06-01T00:00:00Z.
|
| Teme: | |
| Online dostop: | Connect to this object online. |
| Oznake: |
Označite
Brez oznak, prvi označite!
|
Internet
Connect to this object online.3rd Floor Main Library
| Signatura: |
A1234.567 |
|---|---|
| Kopija 1 | Prosto |